Unknown

Dataset Information

0

Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy.


ABSTRACT: Neoadjuvant chemotherapy (NAC) is often the treatment of choice for borderline resectable and locally advanced invasive pancreatic ductal adenocarcinoma (PDAC); however, most cancers only partially respond to therapy. We hypothesized that the location of residual neoplastic cells in resected specimens following NAC could provide a clue as to the mechanisms of resistance. PDAC cells invade the stroma but can also invade back into and spread via the pancreatic ducts, which has been referred to as "cancerization of ducts" (COD). We compared the responsiveness to chemotherapy between PDAC cells in the stroma and PDAC cells in the duct. Pancreatic resections from a total of 174 PDAC patients (NAC, n?=?97; immediate surgery, n?=?77) were reviewed. On hematoxylin and eosin sections, COD was identified at the same prevalence in both groups (NAC: 50/97 cases, 52%; immediate surgery: 39/77 cases, 51%; p?=?0.879, Fisher's exact test). However, using quantitative image analysis of CK19 immunohistochemistry, we found that the proportion of cancer cells that were intraductal was significantly different between the NAC and immediate surgery groups (median; 12.7% vs. 1.99%, p?

SUBMITTER: Fujikura K 

PROVIDER: S-EPMC7529702 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy.

Fujikura Kohei K   Hutchings Danielle D   Braxton Alicia M AM   Zhu Qingfeng Q   Laheru Daniel A DA   Hruban Ralph H RH   Thompson Elizabeth D ED   Wood Laura D LD  

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20200526 10


Neoadjuvant chemotherapy (NAC) is often the treatment of choice for borderline resectable and locally advanced invasive pancreatic ductal adenocarcinoma (PDAC); however, most cancers only partially respond to therapy. We hypothesized that the location of residual neoplastic cells in resected specimens following NAC could provide a clue as to the mechanisms of resistance. PDAC cells invade the stroma but can also invade back into and spread via the pancreatic ducts, which has been referred to as  ...[more]

Similar Datasets

| S-EPMC7372733 | biostudies-literature
| S-EPMC5452906 | biostudies-other
| S-ECPF-GEOD-4779 | biostudies-other
| S-EPMC10202108 | biostudies-literature
2008-12-19 | E-GEOD-4779 | biostudies-arrayexpress
| S-EPMC10079604 | biostudies-literature
| S-EPMC7797682 | biostudies-literature
| S-EPMC9746809 | biostudies-literature
2008-12-19 | GSE4779 | GEO
| S-EPMC4858137 | biostudies-literature